Insight Molecular Diagnostics Share Price (NASDAQ: IMDX)
$2.57
▲
0.06
(2.39%)
Last updated on
Check the interactive Insight Molecular Diagnostics Stock chart to analyse performance
Insight Molecular Diagnostics stock performance
as on August 30, 2025 at 1:28 am IST
- Today's Low:$2.51Today's High:$2.57
2.33%
Downside
Day's Volatility :2.33%
Upside
0.0%
- 52 Weeks Low:$2.3352 Weeks High:$4.24
9.34%
Downside
52 Weeks Volatility :45.05%
Upside
39.39%
Insight Molecular Diagnostics Stock Returns
Insight Molecular Diagnostics Inc Key Stats
Check Insight Molecular Diagnostics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Insight Molecular Diagnostics Stock including INR - Dollar returns
The Insight Molecular Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Insight Molecular Diagnostics investment value today
Current value as on today
₹88,456
Returns
Returns from Insight Molecular Diagnostics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Insight Molecular Diagnostics Stock
Analyst Recommendation on Insight Molecular Diagnostics Stock
Insight Molecular Diagnostics Share Price Target
What analysts predicted
Upside of 110.77%
Target:
$5.42
Current:
$2.57
Insight Molecular Diagnostics share price target is $5.42, a slight Upside of 110.77% compared to current price of $2.57 as per analysts' prediction.
Insight Molecular Diagnostics Stock Insights
Price Movement
In the last 3 months, IMDX stock has moved down by -23.8%Decreasing Revenue
Revenue is down for the last 2 quarters, 2.13M → 518.0K (in $), with an average decrease of 75.8% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -6.67M → -9.74M (in $), with an average decrease of 46.0% per quarterIMDX vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 53.6%IMDX vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.8% return, outperforming this stock by 169.8%Price to Sales
ForIMDX every $1 of sales, investors are willing to pay $11.4, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.
Insight Molecular Diagnostics Inc Financials
Insight Molecular Diagnostics Technicals Summary
Sell
Neutral
Buy
Insight Molecular Diagnostics is currently in a neutral trading position according to technical analysis indicators.
Insight Molecular Diagnostics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -1.17% | -8.99% | -18.12% | -83.96% | -89.46% |
 | 10.74% | -0.51% | -9.55% | -2.51% | 24.3% |
 | 20.6% | 47.74% | 37.7% | 84.56% | 62.07% |
 | 6.38% | -5.93% | -18.77% | -10.56% | 13.57% |
 | 4.47% | 0.1% | -22.08% | -24.82% | -1.19% |
 | 4.47% | 3.11% | -23.4% | -9.93% | 15.42% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.99 | -4.29 | -0.22 | NA | 0.36 |
| 29.29 | 29.29 | 1.84 | 5.57 | 0.2 | 0.08 | 0.0 | 22.46 |
| 53.78 | 53.78 | 4.84 | 12.6 | 0.65 | 0.23 | NA | 18.2 |
| 28.33 | 28.33 | 1.99 | 22.49 | 0.13 | 0.05 | 0.0 | 133.77 |
| 43.68 | 43.68 | 2.06 | 7.77 | 0.07 | 0.04 | 0.01 | 73.1 |
| 27.61 | 27.61 | 1.08 | 11.87 | 0.2 | 0.05 | NA | 33.99 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| NA | $86.7M | -89.46% | NA | 0.0% |
| Buy | $35.7B | 24.3% | 29.29 | 17.97% |
| Buy | $51.8B | 62.07% | 53.78 | 24.41% |
| Buy | $184.9B | 13.57% | 28.33 | 15.24% |
| Buy | $147.0B | -1.19% | 43.68 | 14.21% |
| Buy | $32.4B | 15.42% | 27.61 | 7.88% |
About Insight Molecular Diagnostics Inc
Key Management of Insight Molecular Diagnostics Inc
Important FAQs about investing in IMDX Stock from India :
What is Insight Molecular Diagnostics share price today?
Insight Molecular Diagnostics share price today is $2.57 as on at the close of the market. Insight Molecular Diagnostics share today touched a day high of $2.57 and a low of $2.51.
What is the 52 week high and 52 week low for Insight Molecular Diagnostics share?
Insight Molecular Diagnostics share touched a 52 week high of $4.24 and a 52 week low of $2.33. Insight Molecular Diagnostics stock price today i.e. is closed at $2.57, lower by 39.39% versus the 52 week high.
How to invest in Insight Molecular Diagnostics Stock (IMDX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Insight Molecular Diagnostics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insight Molecular Diagnostics Shares that will get you 0.5837 shares as per Insight Molecular Diagnostics share price of $2.57 per share as on August 30, 2025 at 1:28 am IST.
What is the minimum amount required to buy Insight Molecular Diagnostics Stock (IMDX) from India?
Indian investors can start investing in Insight Molecular Diagnostics (IMDX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Insight Molecular Diagnostics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Insight Molecular Diagnostics share’s latest price of $2.57 as on August 30, 2025 at 1:28 am IST, you will get 3.8911 shares of Insight Molecular Diagnostics. Learn more about
fractional shares .
What are the returns that Insight Molecular Diagnostics has given to Indian investors in the last 5 years?
Insight Molecular Diagnostics stock has given -89.46% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%